RBC Capital Markets’s $130 target on ABT

ABT Abbott Laboratories

$101 → $130 (+29%) by Jul 2027

Outperform · reiterates · said Jul 17, 2026 · 12-month default horizon

Open: judged on the close on Jul 17, 2027

The article this target came from

ABT Reiterated by RBC Capital -- Price Target Maintained at $130

GuruFocus · Jul 17, 2026

ABT Reiterated by RBC Capital -- Price Target Maintained at $130

RBC Capital Markets’s track record → Abbott Laboratories →

A fact about what RBC Capital Markets published, as reported by GuruFocus, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.